1[1]Russell SB, Trupin KM, Rodriguez Eaton S, et al. Reduced growth-factor requirement of keloid-derived fibroblasts may account for tumor growth[J]. Proc Natl Acad Sci USA, 1988, 85(2): 587.
2[2]Hofmockel G, Tsatalpas P, Muller H, et al. Significance of conventional and new prognostic factors for locally confined renal cell carcinoma[J]. Cancer, 1995, 76(2): 296.
3[3]Gavrieli Y, Shermany Y, Ben Sasson SA, et al. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation[J]. J cell Biol, 1992, 119(3): 493.
4[4]Kischer CW. The microvessels in hypertrophic scars, keliods and related lesions: a review[J]. J Submicrosc Cytol Pathol, 1992, 24(2): 281.
5Leask A, Holmes A, Abraham DJ. Connective tissue growth factor: a new and important player in the pathogenesis of fibrosis. Curr Rheumatol Rep, 2002; 4(2): 136.
7Bradham DM, Igarashi A, Potter RL, et al. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol, 1991, 114(6): 285.
8Grotendorst GR, Okochi H, Hayashi N. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ, 1996; 7(4): 469.
9Holmes A, Abraham DJ, Sa S, etal. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem, 2001, 276(14) : 10 594.
